Braskem S.A. Reports Strong Financial Growth in Q1 2025

The latest update is out from Braskem SA ( (BAK) ).

Braskem S.A. reported a significant improvement in its financial performance for the first quarter of 2025, with a recurring EBITDA of US$224 million, marking a 121% increase from the previous quarter. The company’s operations in Brazil/South America, the United States, Europe, and Mexico showed varied performance, with notable increases in utilization rates and sales volumes in certain segments. Despite a negative operating cash generation due to inventory management and debt interest payments, Braskem maintained a strong cash position to cover upcoming debt maturities, indicating robust financial health and strategic operational management.

The most recent analyst rating on (BAK) stock is a Buy with a $8.50 price target. To see the full list of analyst forecasts on Braskem SA stock, see the BAK Stock Forecast page.

Spark’s Take on BAK Stock

According to Spark, TipRanks’ AI Analyst, BAK is a Neutral.

Braskem’s overall stock score of 47 reflects its financial instability, marked by high leverage and declining profitability. While recent earnings call highlights, such as increased EBITDA and operating cash generation, offer some optimism, the technical analysis and valuation concerns weigh heavily on the stock’s attractiveness. The company’s strategic focus on operational efficiency and green business initiatives could improve its long-term position, but significant risks remain in the short term.

To see Spark’s full report on BAK stock, click here.

More about Braskem SA

Braskem S.A. is the largest resin producer in the Americas and a global leader in biopolymers. The company operates in the petrochemical industry, focusing on the production of polyethylene (PE), polypropylene (PP), and polyvinyl chloride (PVC), with significant operations in Brazil, South America, the United States, Europe, and Mexico.

Average Trading Volume: 800,203

Technical Sentiment Signal: Sell

Current Market Cap: $1.46B

For a thorough assessment of BAK stock, go to TipRanks’ Stock Analysis page.